Matthew Barry Global Insight Manager: Food, Cooking and Meals
chicago
English
About Matthew
Matt is Global Insight Manager for Food, Cooking and Meals at Euromonitor International. He focuses on providing insights to large food clients but also supports in the wider space including beverage companies, government agencies, and suppliers.
Expertise
Matt advises clients in the food, beverages, and B2B space on a wide variety of topics. Particular interest areas include cooking ingredients and meals, hot drinks, functional food and beverage, and the impact of geopolitics on food. Matt holds a master's degree in International Relations from the Harvard University School of Extension Studies. He has been quoted in publications such as the Economist, The Financial Times, and The Wall Street Journal.
Recently Published Work
Proteinmaxxing and the Future of Protein Demand
13 Jul 26At a time when the food industry is struggling under the combined pressure of tough demographics, consumers pulling back on spending, geopolitical trouble, and rising costs of inputs, there has been at least one notable bright spot: protein. Consumers have shown a remarkable and enduring interest in high-protein products in virtually every format and category. But how long can this last? Are we nearing the end of the Age of Proteinmaxxing?
Matthew Barry
Top Five Trends Shaping the Cooking Ingredients and Meals Industry in 2026
13 Apr 26The food consumer of 2026 faces numerous challenges. Foremost amongst these is rising prices, a trend likely to worsen as the supply disruptions of the war in Iran disrupt the global agricultural system. This is going to push consumers to above all seek value. They are willing to splurge less than they were before, but that does not mean they are not still willing to spend on things such as health benefits and convenience if the value proposition is right.
Matthew Barry
The Impact of GLP-1 Drugs on Food and Beverage Demand
19 Jun 25The use of GLP-1 drugs, which is already exerting a significant impact on the US food and beverage market, is set to rise sharply around the world in 2026. Semaglutide, the active ingredient in drugs like Ozempic, goes off-patent in much of the world that year. This means that millions of people are going to change how they eat and drink in the coming years, with significant impacts on the food and drink industry.
Matthew Barry